These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12552302)

  • 1. Inflammation, atherosclerosis and predicting cardiovascular risk.
    Williams M; Stewart R
    N Z Med J; 2002 Oct; 115(1163):U196. PubMed ID: 12552302
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammation and atherosclerosis.
    Steffens S; Mach F
    Herz; 2004 Dec; 29(8):741-8. PubMed ID: 15599670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atherosclerosis not caused by overindulgence only. Infection may be a risk factor for cardiovascular disease].
    Schäfer Elinder L; Frostegård J
    Lakartidningen; 1998 May; 95(19):2203-6. PubMed ID: 9623050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidelines for the prevention and treatment of atherosclerosis and cardiovasculer diseases: treatment of diabetes mellitus, dyslipidemia and the prevention of stroke].
    Bitzur R; Harats D; Rubinstein A
    Harefuah; 2005 Sep; 144(9):647-54, 675. PubMed ID: 16218538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polish Forum for Prevention Guidelines on the so-called new cardiovascular risk factors and markers, which have a potentially significant role in the strategy for the prevention of cardiovascular diseases.
    Undas A; Podolec P; Kopeć G; Pajak A; Gasior Z; Małecki M; Pasowicz M; Rynkiewicz A; Torbicki A; Zdrojeski T; Czarnecka D; Drygas W; Godycki-Cwirko M; Kozek E; Naruszewicz M; Opala G; Stańczyk J; Sieradzki J
    Kardiol Pol; 2007 Nov; 65(11):1396-8. PubMed ID: 18303602
    [No Abstract]   [Full Text] [Related]  

  • 6. European guidelines on cardiovascular disease prevention in clinical practice: past, present, and future: a need for joint forces.
    Cífková R; Mancia G; Kjeldsen SE; Laurent S
    J Hypertens; 2008 Feb; 26(2):157-60. PubMed ID: 18192823
    [No Abstract]   [Full Text] [Related]  

  • 7. [Atherosclerosis: which are the tools available for the practionner?].
    Hayoz D
    Rev Med Suisse; 2005 Jan; 1(4):299-300, 302, 304-5. PubMed ID: 15771360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk evaluation in action for cardiovascular health.
    Gilski DJ; Borkenhagen B
    Crit Care Nurse; 2005 Feb; 25(1):26-8, 30-7. PubMed ID: 15756731
    [No Abstract]   [Full Text] [Related]  

  • 9. [What are the biomarkers of atherosclerosis and cardiovascular risk?].
    Riesen WF
    Rev Med Suisse; 2008 Mar; 4(148):636-8, 640-3. PubMed ID: 18459658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis.
    Sangle SR; Davies RJ; Mora M; Baron MA; Hughes GR; D'Cruz DP
    Rheumatology (Oxford); 2008 Jul; 47(7):1058-60. PubMed ID: 18499719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis and Folic Acid Supplementation Trial: untangling the web of cardiac risk in chronic kidney disease.
    Kelly JJ; Kohlhagen J
    Nephrology (Carlton); 2004 Jun; 9(3):112-3. PubMed ID: 15189169
    [No Abstract]   [Full Text] [Related]  

  • 12. The Fleming Unified Theory of Vascular Disease: a link between atherosclerosis, inflammation, and bacterially aggravated atherosclerosis (BAA).
    Fleming RM
    Angiology; 2000 Jan; 51(1):87-9. PubMed ID: 10667648
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychosocial risk factors in therapeutic guidelines for cardiovascular risk].
    Orth-Gomér K
    Lakartidningen; 2004 Dec; 101(49):4053. PubMed ID: 15633352
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inflammatory markers and cytokines in cardiovascular disease].
    Ogiwara F; Takahashi M; Ikeda U
    Rinsho Byori; 2004 Aug; 52(8):686-92. PubMed ID: 15478624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Emerging risk factors and prevention of atherosclerosis in uraemia].
    Timio M; Saronio P; Verdura C; Venanzi S; Timio F
    G Ital Nefrol; 2003; 20 Suppl 22():S17-21. PubMed ID: 12851916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein: a novel marker of cardiovascular risk.
    Shah SH; Newby LK
    Cardiol Rev; 2003; 11(4):169-79. PubMed ID: 12852794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial.
    D'Aiuto F; Parkar M; Nibali L; Suvan J; Lessem J; Tonetti MS
    Am Heart J; 2006 May; 151(5):977-84. PubMed ID: 16644317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of atherosclerosis].
    Ruiz Moreno M
    An Esp Pediatr; 1986 Jan; 24(1):3-6. PubMed ID: 3963642
    [No Abstract]   [Full Text] [Related]  

  • 20. [Guidelines for the prevention and treatment of atherosclerosis and cardiovasculer diseases: general recommendations--hypertension].
    Bitzur R; Harats D; Rubinstein A;
    Harefuah; 2005 Jul; 144(7):506-12, 525. PubMed ID: 16082905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.